Latest Tri Locum Partners LP Stock Portfolio
$712Million– No. of Holdings #17
Tri Locum Partners LP Performance:
2026 Q1: 3.12%YTD: 3.12%2025: 17.81%
Performance for 2026 Q1 is 3.12%, and YTD is 3.12%, and 2025 is 17.81%.
About Tri Locum Partners LP and 13F Hedge Fund Stock Holdings
On 2026-05-18, the fund reported it's updated stock portfolio. In the 13F Holdings report, Tri Locum Partners LP reported an equity portfolio of $712.5 Millions as of 31 Mar, 2026.
The top stock holdings of Tri Locum Partners LP are JNJ, ISRG, TMO. The fund has invested 14.2% of it's portfolio in JOHNSON & JOHNSON and 9.9% of portfolio in INTUITIVE SURGICAL INC.
The fund managers got completely rid off DANAHER CORPORATION (DHR), BOSTON SCIENTIFIC CORP (BSX) and IONIS PHARMACEUTICALS INC (IONS) stocks. They significantly reduced their stock positions in DIANTHUS THERAPEUTICS INC, AXSOME THERAPEUTICS INC. (AXSM) and UNITED THERAPEUTICS CORP DEL (UTHR). Tri Locum Partners LP opened new stock positions in INTUITIVE SURGICAL INC (ISRG), THERMO FISHER SCIENTIFIC INC (TMO) and VERTEX PHARMACEUTICALS INC (VRTX). The fund showed a lot of confidence in some stocks as they added substantially to DEXCOM INC (DXCM), MADRIGAL PHARMACEUTICALS INC (MDGL) and NUVALENT INC (NUVL).
The top stock holdings of Tri Locum Partners LP are JNJ, ISRG, TMO. The fund has invested 14.2% of it's portfolio in JOHNSON & JOHNSON and 9.9% of portfolio in INTUITIVE SURGICAL INC.
The fund managers got completely rid off DANAHER CORPORATION (DHR), BOSTON SCIENTIFIC CORP (BSX) and IONIS PHARMACEUTICALS INC (IONS) stocks. They significantly reduced their stock positions in DIANTHUS THERAPEUTICS INC, AXSOME THERAPEUTICS INC. (AXSM) and UNITED THERAPEUTICS CORP DEL (UTHR). Tri Locum Partners LP opened new stock positions in INTUITIVE SURGICAL INC (ISRG), THERMO FISHER SCIENTIFIC INC (TMO) and VERTEX PHARMACEUTICALS INC (VRTX). The fund showed a lot of confidence in some stocks as they added substantially to DEXCOM INC (DXCM), MADRIGAL PHARMACEUTICALS INC (MDGL) and NUVALENT INC (NUVL).
Tri Locum Partners LP Equity Portfolio Value
Last Reported on: 18 May, 2026
Tri Locum Partners LP Annual Return Estimates Vs S&P 500
Our best estimate is that Tri Locum Partners LP made a return of 3.12% in the last quarter. In trailing 12 months, it's portfolio return was 25.48%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| intuitive surgical inc | 70,646,700 |
| thermo fisher scientific inc | 65,085,000 |
| vertex pharmaceuticals inc | 57,743,900 |
| jazz pharmaceuticals plc | 29,995,200 |
| tarsus pharmaceuticals inc | 17,719,000 |
| definium therapeutics inc | 6,985,210 |
New stocks bought by Tri Locum Partners LP
Additions
| Ticker | % Inc. |
|---|---|
| dexcom inc | 65.6 |
| madrigal pharmaceuticals inc | 20.07 |
| nuvalent inc | 0.37 |
Additions to existing portfolio by Tri Locum Partners LP
Reductions
| Ticker | % Reduced |
|---|---|
| dianthus therapeutics inc | -76.62 |
| axsome therapeutics inc. | -69.19 |
| united therapeutics corp del | -41.8 |
| johnson & johnson | -31.28 |
| teva pharmaceutical inds ltd | -28.89 |
| argenx se | -15.98 |
| ascendis pharma a/s | -3.65 |
| eli lilly & co | -2.35 |
Tri Locum Partners LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| vera therapeutics inc | -40,800,100 |
| ionis pharmaceuticals inc | -44,078,000 |
| boston scientific corp | -49,630,400 |
| danaher corporation | -79,406,600 |
Tri Locum Partners LP got rid off the above stocks
Sector Distribution
Tri Locum Partners LP has about 85.9% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 85.9 |
| Others | 14.1 |
Market Cap. Distribution
Tri Locum Partners LP has about 77.5% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- MEGA-CAP
- UNALLOCATED
- MID-CAP
| Category | % |
|---|---|
| LARGE-CAP | 55.3 |
| MEGA-CAP | 22.2 |
| UNALLOCATED | 14.1 |
| MID-CAP | 8.4 |
Stocks belong to which Index?
About 71.5% of the stocks held by Tri Locum Partners LP either belong to S&P 500 or RUSSELL 2000 index.
- S&P 500
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| S&P 500 | 55.5 |
| Others | 28.5 |
| RUSSELL 2000 | 16 |
Tri Locum Partners LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Tri Locum Partners LP
Tri Locum Partners LP has 17 stocks in it's portfolio. About 81.6% of the portfolio is in top 10 stocks. LLY proved to be the most loss making stock for the portfolio. JNJ was the most profitable stock for Tri Locum Partners LP last quarter.
Last Reported on: 18 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ARGX | argenx se | 3.24 | 31,635 | 23,101,500 | reduced | -15.98 | ||
| ASND | ascendis pharma a/s | 8.20 | 255,332 | 58,402,100 | reduced | -3.65 | ||
| AXSM | axsome therapeutics inc. | 1.47 | 62,116 | 10,498,800 | reduced | -69.19 | ||
| BSX | boston scientific corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DHR | danaher corporation | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DXCM | dexcom inc | 6.15 | 698,158 | 43,844,300 | added | 65.6 | ||
| IONS | ionis pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ISRG | intuitive surgical inc | 9.91 | 153,250 | 70,646,700 | new | |||
| JAZZ | jazz pharmaceuticals plc | 4.21 | 158,663 | 29,995,200 | new | |||
| JNJ | johnson & johnson | 14.22 | 414,503 | 101,321,000 | reduced | -31.28 | ||
| LLY | eli lilly & co | 7.98 | 61,795 | 56,837,200 | reduced | -2.35 | ||
| MDGL | madrigal pharmaceuticals inc | 7.59 | 103,288 | 54,068,200 | added | 20.07 | ||
| NUVL | nuvalent inc | 4.44 | 308,506 | 31,606,400 | added | 0.37 | ||
| TARS | tarsus pharmaceuticals inc | 2.49 | 252,588 | 17,719,000 | new | |||
| TEVA | teva pharmaceutical inds ltd | 4.32 | 1,021,010 | 30,752,800 | reduced | -28.89 | ||
| TMO | thermo fisher scientific inc | 9.13 | 132,413 | 65,085,000 | new | |||
| UTHR | united therapeutics corp del | 5.86 | 70,370 | 41,728,000 | reduced | -41.8 | ||
| VERA | vera therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| VRTX | vertex pharmaceuticals inc | 8.10 | 129,314 | 57,743,900 | new | |||
| dianthus therapeutics inc | 1.71 | 145,543 | 12,214,000 | reduced | -76.62 | |||